Introduction Executive Summary Peripheral nerve injuries: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Peripheral nerve injuries – DelveInsight’s Analytical Perspective Late Stage Products (Phase III) • Comparative Analysis Drug name: Company name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis NTX-001: Neuraptive Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Recombinant Interleukin-6: Sonnet Biotherapeutics Holdings • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical/Discovery Stage Products • Comparative Analysis Liatermin: MedGenesis Therapeutix • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Peripheral nerve injuries Key Companies Peripheral nerve injuries Key Products Peripheral nerve injuries- Unmet Needs Peripheral nerve injuries- Market Drivers and Barriers Peripheral nerve injuries- Future Perspectives and Conclusion Peripheral nerve injuries Analyst Views Appendix

Table 1 Total Products for Peripheral nerve injuries Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Neuraptive Therapeutics • MicroCures • SanBio • KannaLife Sciences • Sonnet BioTherapeutics • Ono Pharmaceutical • AxoGen • MedGenesis Therapeutix • Tetragenetics